Update of COVID-19 and MS – Morbidity and mortality figures

In this webinar, experts share insights on the impact of disease modifying therapies during early phase of the pandemic in the UK and in Italy and go through case histories

Like Comment


  • Prof Richard Nicholas, Consultant Neurologist, Imperial College Healthcare NHS Trust
  • Prof Marco Salvetti, Professor of Neurology, Sapienza University of Rome, Italy
  • Prof Gavin Giovannoni, Professor of Neurology, Barts and The London School of Medicine and Dentistry & Academic Director, MS Academy

To view full video register to OnMedica and then click 'View full content'. 


Neurology Academy

The Neurology Academy is an innovative education provider for clinicians, specialist nurses and professions allied to medicine. The training program focus is on both disease management and service transformation. Each priority condition is led by an Academic Faculty of practicing clinicians who operate within a separate disease focussed Academy. Course attendees improve their own understanding in management of the condition as well as working towards improvements in their own local services through audit, data, education and networking. Current Academy priorities are multiple sclerosis, Parkinson’s disease, dementia, palliative care and neuropharmacy.

7 Contributions
0 Following